Literature DB >> 32254314

Timely coordinated phototherapy mediated by mesoporous organosilica coated triangular gold nanoprisms.

Wenfei Liu1, Ying Tian, Yunlei Zhang, Kai Liu, Shuang Zhao, Junjie Zhang, Yunyan Su, Ying Zhao, Yuxia Tang, Jing Sun, Wei Tian, Liang Song, Zhaogang Teng, Shouju Wang, Guangming Lu.   

Abstract

A variety of nanocarriers have been designed to deliver photosensitizers (PSs) and promote the clinical applications of photodynamic therapy (PDT). However, most of them suffer from insufficient loading capability, premature leakage, and/or unstable therapeutic efficacy. Herein, we constructed a novel nanocomposite (TGP@MOS) with a benzene-bridged mesoporous organosilica shell and a triangular gold nanoprism core. The TGP@MOS could load model PS molecules, zinc phthalocyanine (ZnPc), with high loading capacity (11.8 wt%) and minimal premature leakage (only 2.6% after incubation in PBS with 10% FBS for 60 h) viaπ-π stacking interactions and hydrophobic interactions. We demonstrated that the obtained TGP@MOS-ZnPc could realize timely coordinated photodynamic/photothermal therapy upon single irradiation, and thus stabilize and maximize the therapeutic efficacy of phototherapy both in vitro and in vivo. Other advantages of TGP@MOS-ZnPc include excellent water solubility, stability, hemocompatibility and biocompatibility.

Entities:  

Year:  2018        PMID: 32254314     DOI: 10.1039/c8tb00541a

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  2 in total

1.  Photosensitizer-loaded biomimetic platform for multimodal imaging-guided synergistic phototherapy.

Authors:  Ying Tian; Ying Zhao; Wenfei Liu; Ying Liu; Yuxia Tang; Zhaogang Teng; Chunni Zhang; Shouju Wang; Guangming Lu
Journal:  RSC Adv       Date:  2018-09-18       Impact factor: 4.036

2.  Treatment of breast cancer in vivo by dual photodynamic and photothermal approaches with the aid of curcumin photosensitizer and magnetic nanoparticles.

Authors:  Ali Ashkbar; Fatemeh Rezaei; Farnoosh Attari; Saboura Ashkevarian
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.